Literature DB >> 21989743

Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity.

Xuefang Ren1, Kozaburo Akiyoshi, Marjorie R Grafe, Arthur A Vandenbark, Patricia D Hurn, Paco S Herson, Halina Offner.   

Abstract

Although inflammatory responses increase stroke severity, the role of immune cells specific for central nervous system (CNS) antigens remains controversial. Disruption of the blood-brain barrier (BBB) during stroke allows CNS antigens to leak into the peripheral circulation and enhances access of circulating leukocytes to the brain, including those specific for CNS antigens such as myelin oligodendrocyte glycoprotein (MOG) that can induce experimental autoimmune encephalomyelitis (EAE). We here demonstrate for the first time that myelin reactive splenocytes specific for MOG transferred into severe combined immunodeficient (SCID) mice can migrate into the infarct hemisphere of recipients subjected to 60 min middle cerebral artery occlusion (MCAO) and 96 h reperfusion; moreover these cells exacerbate infarct volume and worsen neurological deficits compared to animals transferred with naïve splenocytes. These findings indicate that autoimmunity in the CNS can exert detrimental injury on brain cells and worsen the damage from ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989743      PMCID: PMC3270145          DOI: 10.1007/s11011-011-9267-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  44 in total

1.  Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke.

Authors:  Fabrizio Montecucco; Sébastien Lenglet; Angèle Gayet-Ageron; Maria Bertolotto; Graziano Pelli; Domenico Palombo; Bianca Pane; Giovanni Spinella; Sabine Steffens; Lizzia Raffaghello; Vito Pistoia; Luciano Ottonello; Aldo Pende; Franco Dallegri; François Mach
Journal:  Stroke       Date:  2010-06-10       Impact factor: 7.914

2.  Flow cytometric analysis of inflammatory cells in ischemic rat brain.

Authors:  Marilena Campanella; Clara Sciorati; Glauco Tarozzo; Massimiliano Beltramo
Journal:  Stroke       Date:  2002-02       Impact factor: 7.914

Review 3.  T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  J M Fletcher; S J Lalor; C M Sweeney; N Tubridy; K H G Mills
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

4.  Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice.

Authors:  Jean Pierre S Peron; Kayong Yang; Mei-Ling Chen; Wesley Nogueira Brandao; Alexandre S Basso; Alessandra G Commodaro; Howard L Weiner; Luiz V Rizzo
Journal:  J Neuroimmunol       Date:  2010-07-02       Impact factor: 3.478

5.  Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.

Authors:  K J Becker; R M McCarron; C Ruetzler; O Laban; E Sternberg; K C Flanders; J M Hallenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 6.  Chemokine receptors.

Authors:  R Horuk
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

Review 7.  Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS.

Authors:  Marco Prinz; Josef Priller
Journal:  J Neuroimmunol       Date:  2010-05-31       Impact factor: 3.478

8.  Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice.

Authors:  Suzan Dziennis; Sarah Mader; Kozaburo Akiyoshi; Xuefang Ren; Patricia Ayala; Gregory G Burrows; Arthur A Vandenbark; Paco S Herson; Patricia D Hurn; Halina A Offner
Journal:  Metab Brain Dis       Date:  2011-04-07       Impact factor: 3.584

9.  T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis.

Authors:  Magdalena J Polanczyk; Richard E Jones; Sandhya Subramanian; Michael Afentoulis; Cathleen Rich; Melissa Zakroczymski; Paul Cooke; Arthur A Vandenbark; Halina Offner
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat.

Authors:  J S Kim; S C Gautam; M Chopp; C Zaloga; M L Jones; P A Ward; K M Welch
Journal:  J Neuroimmunol       Date:  1995-02       Impact factor: 3.478

View more
  29 in total

1.  Autoimmune responses to brain following stroke.

Authors:  Kyra Becker
Journal:  Transl Stroke Res       Date:  2012-04-05       Impact factor: 6.829

2.  Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.

Authors:  Liu Yang; Ying Kong; Honglei Ren; Minshu Li; Chang-Juan Wei; Elaine Shi; Wei-Na Jin; Junwei Hao; Arthur A Vandenbark; Halina Offner
Journal:  Neurochem Int       Date:  2016-11-21       Impact factor: 3.921

Review 3.  Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures?

Authors:  Aditya Rayasam; Martin Hsu; Julie A Kijak; Lee Kissel; Gianna Hernandez; Matyas Sandor; Zsuzsanna Fabry
Journal:  Immunology       Date:  2018-03-26       Impact factor: 7.397

4.  2014 Thomas Willis Award Lecture: sex, stroke, and innovation.

Authors:  Patricia D Hurn
Journal:  Stroke       Date:  2014-10-21       Impact factor: 7.914

5.  Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke.

Authors:  Wenbin Zhu; Amanda Casper; Nicole L Libal; Stephanie J Murphy; Sheetal Bodhankar; Halina Offner; Nabil J Alkayed
Journal:  Transl Stroke Res       Date:  2014-10-02       Impact factor: 6.829

Review 6.  Partial MHC class II constructs as novel immunomodulatory therapy for stroke.

Authors:  Gil Benedek; Arthur A Vandenbark; Nabil J Alkayed; Halina Offner
Journal:  Neurochem Int       Date:  2016-10-31       Impact factor: 3.921

Review 7.  The impact of sex and age on T cell immunity and ischemic stroke outcomes.

Authors:  Hilda Ahnstedt; Louise D McCullough
Journal:  Cell Immunol       Date:  2019-08-01       Impact factor: 4.868

Review 8.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 9.  Long-term T cell responses in the brain after an ischemic stroke.

Authors:  Uma Maheswari Selvaraj; Ann M Stowe
Journal:  Discov Med       Date:  2017-12       Impact factor: 2.970

Review 10.  Molecular and cellular immune responses to ischemic brain injury.

Authors:  Hilary A Seifert; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2014-06-05       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.